| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Hypertension, Essential
[description not available] | 0 | 6.37 | 4 | 3 |
Essential Hypertension
Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500 | 0 | 6.37 | 4 | 3 |
Blood Pressure, High
[description not available] | 0 | 4.87 | 3 | 2 |
Hypertension
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. | 0 | 9.87 | 3 | 2 |
Blood Pressure, Low
[description not available] | 0 | 2.6 | 1 | 0 |
Hypotension
Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. | 0 | 2.6 | 1 | 0 |
Hyperuricemia
Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. | 0 | 2.6 | 1 | 0 |
Alloxan Diabetes
[description not available] | 0 | 2.31 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 2.31 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 7.31 | 1 | 0 |
Diabetic Cardiomyopathies
Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance. | 0 | 2.31 | 1 | 0 |
Apoplexy
[description not available] | 0 | 2.31 | 1 | 0 |
Brain Vascular Disorders
[description not available] | 0 | 2.31 | 1 | 0 |
Aortic Diseases
Pathological processes involving any part of the AORTA. | 0 | 2.31 | 1 | 0 |
Cerebrovascular Disorders
A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. | 0 | 2.31 | 1 | 0 |
Stroke
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) | 0 | 7.31 | 1 | 0 |
Pulmonary Arterial Remodeling
[description not available] | 0 | 2.31 | 1 | 0 |
Goldblatt Syndrome
[description not available] | 0 | 2.31 | 1 | 0 |
Hypertension, Renovascular
Hypertension due to RENAL ARTERY OBSTRUCTION or compression. | 0 | 2.31 | 1 | 0 |
Cardiac Remodeling, Ventricular
[description not available] | 0 | 3.59 | 1 | 1 |
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.08 | 1 | 0 |